🇺🇸 FDA
Patent

US 7919088

Treatment and delay of onset of synucleinopathic and amyloidogenic disease

granted A61KA61K2039/505A61P

Quick answer

US patent 7919088 (Treatment and delay of onset of synucleinopathic and amyloidogenic disease) held by The Regents of the University of California expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61P, A61P25/00, A61P43/00